ストックスクリーナーアプリを入手
185.62
0.59%
1.09
アフターアワーズ：
185.62
Glaukos Corp (GKOS) 最新ニュース
Glaukos Market Cap More Than Doubles in a Year to $11B - Orange County Business Journal
Glaukos Corporation (NYSE:GKOS) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Oppenheimer Asset Management Inc. Invests $2.73 Million in Glaukos Corporation $GKOS - MarketBeat
3 Stocks That May Be Trading Below Their Estimated Value By Up To 50% - Sahm
Walleye Capital LLC Takes $3.75 Million Position in Glaukos Corporation $GKOS - MarketBeat
Glaukos Insider Sold Shares Worth $10,784,659, According to a Recent SEC Filing - marketscreener.com
Glaukos COO Joseph Gilliam sells $10.7m in stock By Investing.com - Investing.com Nigeria
Insider Selling: Glaukos (NYSE:GKOS) COO Sells 60,000 Shares of Stock - MarketBeat
Glaukos COO Joseph Gilliam sells $10.7m in stock - Investing.com
Glaukos(GKOS.US) Officer Sells US$10.78 Million in Common Stock - Moomoo
Glaukos Corporation (GKOS) Stock Forecasts - Yahoo! Finance Canada
Glaukos (NYSE:GKOS) Hits New 12-Month HighHere's What Happened - MarketBeat
Glaukos Corp stock hits all-time high at 184.45 USD - Investing.com
Glaukos SVP & CFO Alex Thurman sells $3.6m in GKOS stock - Investing.com
Insider Selling: Glaukos (NYSE:GKOS) CFO Sells 20,000 Shares of Stock - MarketBeat
Glaukos Insider Sold Shares Worth $3,602,600, According to a Recent SEC Filing - marketscreener.com
GLAUKOS Corp SEC Filing (Aug 11, 2026) - Stock Titan
Assenagon Asset Management S.A. Has $15.20 Million Stock Position in Glaukos Corporation $GKOS - marketbeat.com
Why Is Glaukos (NYSE:GKOS) Surging Toward the Top of Smallcap Medtech? - Kalkine Media
Glaukos Corporation $GKOS Shares Acquired by Bank of America Corp DE - MarketBeat
Quantinno Capital Management LP Raises Position in Glaukos Corporation $GKOS - MarketBeat
A Look at Glaukos Corp (GKOS) After 5.3% Gain -- GF Value $147.7 - GuruFocus
Glaukos (GKOS) Q2 2026 Earnings Call Transcript - theglobeandmail.com
Glaukos (NYSE: GKOS) insider Alex R. Thurman plans 20,000-share stock sale - Stock Titan
Glaukos Corp (GKOS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Dimensional Fund Advisors LP Sells 6,377 Shares of Glaukos Corporation $GKOS - MarketBeat
Royal Bank of Canada Purchases 12,253 Shares of Glaukos Corporation $GKOS - MarketBeat
California State Teachers Retirement System Purchases 11,871 Shares of Glaukos Corporation $GKOS - MarketBeat
First Trust Advisors LP Acquires 40,798 Shares of Glaukos Corporation $GKOS - MarketBeat
Glaukos posts investor presentation outlining iDose TR, Epioxa launch and pipeline depth - TradingView
Renaissance Technologies LLC Purchases New Shares in Glaukos Corporation $GKOS - MarketBeat
Glaukos (NYSE:GKOS) Raised to "Buy" at Wall Street Zen - marketbeat.com
H.C. Wainwright raises Glaukos stock price target on strong results - Investing.com Nigeria
Glaukos Reports Record Q2 Sales, Raises 2026 Outlook - VisionMonday.com
GKOS Maintained by Stifel -- Price Target Raised to $190 - GuruFocus
Glaukos Q2 Earnings Beat Estimates on iDose TR Growth, Stock Up - Zacks Investment Research
Stifel raises Glaukos stock price target to $190 on revenue outlook - Investing.com Nigeria
UBS Adjusts Price Target on Glaukos Corp to $172 From $150, Maintains Neutral Rating - marketscreener.com
GKOS Maintained by Needham -- Price Target Raised to $201 - GuruFocus
Needham raises Glaukos stock price target to $201 on guidance boost - Investing.com Nigeria
Truist raises Glaukos stock price target to $215 on higher estimates - Investing.com Nigeria
Glaukos (NYSE:GKOS) Reaches New 1-Year High on Strong Earnings - MarketBeat
Glaukos Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Glaukos: Q2 Earnings Snapshot - KTVB
Glaukos Corporation (GKOS) Stock Rises on Q2 2026 Earnings - Quiver Quantitative
Glaukos Corp stock hits 52-week high at 161.67 USD By Investing.com - Investing.com Nigeria
Glaukos Rises as Investors Weigh Clinical Progress Ahead of Earnings - Quiver Quantitative
Glaukos (NYSE:GKOS) Posts Quarterly Earnings Results, Beats Expectations By $0.07 EPS - MarketBeat
Stifel reiterates Glaukos stock rating on Epioxa demand strength By Investing.com - Investing.com Canada
UBS Group Begins Coverage on Glaukos (NYSE:GKOS) - MarketBeat
Glaukos Announces Completion of Patient Enrollment in 510(k) Pivotal Study for PRESERFLO™ MicroShunt - BioSpace
Glaukos Corporation Advances PRESERFLO MicroShunt Study - GuruFocus
Glaukos Corp (GKOS) Income Statement - tradingkey.com
Glaukos Completes Enrollment for Glaucoma Implant Study - Orange County Business Journal
Glaukos Corp Revenue Breakdown – BX:GKOS - TradingView
Glaukos completes enrollment in glaucoma device pivotal study By Investing.com - Investing.com Nigeria
Glaukos (GKOS) Completes Patient Enrollment for Groundbreaking G - GuruFocus
Glaukos completes enrollment in glaucoma device pivotal study - Investing.com
Glaukos completes enrollment with at least 110 glaucoma patients - Stock Titan
Glaukos Corp (GKOS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Bank of New York Mellon Corp Sells 12,667 Shares of Glaukos Corporation $GKOS - MarketBeat
GKOS|Glaukos Corp|Price:166.720|Chg%:-1.750 - TradingKey
Glaukos Corp (GKOS) Balance Sheet - TradingKey
Glaukos Corp (GKOS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
2.43%
大文字化:
|
ボリューム (24 時間):